AI assistant
Sending…
HAEMONETICS CORP — Director's Dealing 2018
Aug 23, 2018
31565_dirs_2018-08-23_9c77d191-700e-4820-a244-91699b914ec7.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: HAEMONETICS CORP (HAE)
CIK: 0000313143
Period of Report: 2018-08-20
Reporting Person: Llorens Josep (SVP, Global Manufacturing)
More from HAEMONETICS CORP
Major Shareholding Notification
2026
May 13
Regulatory Filings
2026
May 7
Regulatory Filings
2026
May 1
Major Shareholding Notification
2026
Apr 30
Major Shareholding Notification
2026
Apr 29
Major Shareholding Notification
2026
Mar 27
Major Shareholding Notification
2026
Mar 4
Regulatory Filings
2026
Mar 3
Major Shareholding Notification
2026
Feb 13
Regulatory Filings
2026
Feb 12